[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"soft-tissue-neoplasms\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:soft-tissue-neoplasms":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,56],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":29,"overallStatus":43,"whyStopped":4,"lastUpdateSubmitDate":44,"lastUpdatePostDateStruct":45,"startDateStruct":48,"completionDateStruct":50,"leadSponsor":52,"locationsCount":55},"100649013","stress-and-anxiety-before-biopsy-after-biopsy-results-and-during-treatment-in-patients-with-suspected-bone-or-soft-tissue-cancer-100649013",false,"NCT07727434","Stress and Anxiety Before Biopsy, After Biopsy Results, and During Treatment in Patients With Suspected Bone or Soft Tissue Cancer","Comparative Evaluation of Psychological Stress and Anxiety Levels Before Biopsy, After Diagnosis, and During Treatment in Patients With Suspected Primary or Metastatic Bone or Soft Tissue Malignancy","BIOPSY-STRESS","Inclusion Criteria:\n\n* Age 18 years or older.\n* Scheduled for biopsy because of a suspected solid tumor.\n* Able to understand and answer the study questionnaires.\n* Able and willing to provide written informed consent before study participation.\n\nExclusion Criteria:\n\n* History of previous malignancy.\n* Current serious psychiatric disorder, including major depressive disorder or psychotic disorder.\n* Cognitive impairment or communication difficulty that prevents valid completion of the study questionnaires.\n* Severe general medical condition or need for emergency intervention that makes study participation inappropriate.","ALL","18 Years",{"count":20,"type":21},100,"ESTIMATED","OBSERVATIONAL","This prospective observational study will follow adults who are scheduled for a clinically indicated biopsy because of a suspected solid tumor involving bone or soft tissue. The period before biopsy, the disclosure of pathology results, and the start of treatment may be associated with changing levels of psychological stress and anxiety.\n\nThe purpose of the study is to compare psychological stress and anxiety in the same participants at three points in their care: before biopsy, after the pathology result or diagnosis is explained, and at treatment initiation. The investigators hypothesize that psychological questionnaire scores will differ across these three time points and may be associated with age, sex, disease stage, metastasis status, and treatment type.\n\nParticipants will complete the Hospital Anxiety and Depression Scale, Perceived Stress Scale, and Distress Thermometer. The study team will also collect relevant demographic and routine clinical information from medical records. The study will not assign any biopsy, diagnostic procedure, or treatment. All diagnostic and treatment decisions will be made by the treating clinical team as part of routine care.",[25,26,27,28],"Bone Neoplasms","Soft Tissue Neoplasms","Anxiety","Stress, Psychological",[30,31,32,33,34,35,36,37,38,27,39,40,41,42],"Orthopedic oncology","Biopsy","Solid tumor","Bone tumor","Soft tissue tumor","Cancer diagnosis","Pathology result disclosure","Treatment initiation","Psychological distress","Depression","Hospital Anxiety and Depression Scale","Perceived Stress Scale","Distress Thermometer","RECRUITING","2026-07-24",{"date":46,"type":47},"2026-07-27","ACTUAL",{"date":49,"type":47},"2026-07-20",{"date":51,"type":21},"2027-01-20",{"name":53,"class":54},"Istanbul University","OTHER",1,{"id":57,"slug":58,"hasResults":11,"nctId":59,"briefTitle":60,"officialTitle":60,"acronym":61,"eligibilityCriteria":62,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":63,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":65,"conditions":66,"keywords":67,"overallStatus":72,"whyStopped":4,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":55},"100591337","investigation-into-the-safety-and-efficacy-of-icg-labeled-fluorescence-imaging-technology-in-guiding-the-resection-of-bone-and-soft-tissue-tumors-100591337","NCT06979115","Investigation Into the Safety and Efficacy of ICG-Labeled Fluorescence Imaging Technology in Guiding the Resection of Bone and Soft Tissue Tumors","ICG-BST","Inclusion Criteria:\n\n1. Histologically confirmed diagnosis of bone and soft tissue tumors (according to the WHO Classification of Tumours of Soft Tissue and Bone, 4th Edition).\n2. Medically fit to undergo surgical treatment based on preoperative evaluation.\n3. Absence of cardiovascular, anesthesia-related, or other surgical contraindications.\n\nExclusion Criteria:\n\n1. Presence of severe or chronic kidney, liver, or pulmonary diseases.\n2. Autonomous thyroid nodules or allergy to iodine\u002Fshellfish.\n3. Deemed unable to tolerate surgery based on preoperative evaluation.",{"count":64,"type":21},40,"Investigate the application protocol, feasibility, and efficacy of indocyanine green (ICG)-assisted near-infrared (NIR) fluorescence-guided resection in bone and soft tissue tumors. Assess the incidence of adverse events and evaluate the safety of the protocol.",[25,26],[68,69,70,71],"Soft tissue neoplasms","Bone neoplasms","Indocyanine green","Near-infrared","NOT_YET_RECRUITING","2025-05-12",{"date":75,"type":47},"2025-05-18",{"date":77,"type":21},"2025-05-25",{"date":79,"type":21},"2028-12-31",{"name":81,"class":54},"Guangdong Provincial People's Hospital"]